Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:OPKO_Health
|
| gptkbp:CEO |
gptkb:Gary_Nabel
|
| gptkbp:focusesOn |
infectious diseases
oncology rare diseases immunotherapies |
| gptkbp:foundedIn |
2021
|
| gptkbp:founder |
gptkb:Elias_Zerhouni
gptkb:Gary_Nabel gptkb:Jean-François_Toussaint |
| gptkbp:headquartersLocation |
gptkb:Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
ModeX Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:parentCompany |
gptkb:OPKO_Health
|
| gptkbp:website |
https://www.modextx.com/
|
| gptkbp:bfsParent |
gptkb:Elizabeth_Nabel
|
| gptkbp:bfsLayer |
5
|